Risk of stroke in patients with atrial fibrillation.
Stiffman
M N
MN
HealthPartners Institute of Medical Education, St. Paul, Minnesota, USA. mstiffman@famprac.umn.edu
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005194:Family Practice; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011446:Prospective Studies; D012306:Risk; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin